The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
EuroIntervention 2016;12:e1336-e1342 published online ahead of print October 2015 published online e-edition December 2016. DOI: 10.4244/EIJY15M10_04
Javaid Iqbal1, MRCP, PhD; Stefan Verheye2, MD, PhD; Alexandre Abizaid3, MD, PhD; John Ormiston4, MB ChB; Ton de Vries5, MSc; Lynn Morrison6, MPH; Sara Toyloy6, BS; Peter Fitzgerald7, MD, PhD; Stephan Windecker8, MD, PhD; Patrick W. Serruys1,9*, MD, PhD; on behalf of EXCELLA II Investigators
1. Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 2. Academisch Ziekenhuis Middelheim, Antwerp, Belgium; 3. Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil; 4. Auckland City Hospital, Auckland, New Zealand; 5. Cardialysis BV, Rotterdam,
Aims: Newer-generation drug-eluting stents (DES) have been shown to be superior to first-generation DES. Current-generation DES have zotarolimus, everolimus or biolimus as antiproliferati
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
drug-eluting stentsnovolimuszotarolimus
Coronary interventionsStents and scaffoldsTools, devices and techniques
Read next article
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Latest news
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022
AHEAD OF PRINT
Antithrombotic strategy selection using smartphone technology
FREE ARTICLE - Jaya Chandrasekhar et al
June 3, 2022
AHEAD OF PRINT
The fingerprints of plaque rupture healing as detected by serial OCT imaging
FREE ARTICLE - Rocco Vergallo et al
June 2, 2022